Strategy& Insider
Podcast autorstwa Thomas Solbach, Ghioia Irritier, Jan-Philipp Loch - Czwartki
33 Odcinki
-
Strategy& Insider Episode 12 – Striving for a better normal in healthcare
Opublikowany: 29.10.2020 -
Strategy& Insider Episode 11 – Fostering digitization in healthcare with an ecosystem approach
Opublikowany: 27.09.2020 -
Strategy& Insider Episode 10 – Bridging gaps in mental healthcare with mobile apps
Opublikowany: 16.07.2020 -
Strategy& Insider Episode 9 - Revolutionizing diagnostics with digital biomarkers
Opublikowany: 22.06.2020 -
Strategy& Insider Episode 8 - Boosting healthcare digitization in times of crisis
Opublikowany: 5.05.2020 -
Strategy& Insider Episode 7 - Balancing individual freedom and collective health
Opublikowany: 22.04.2020 -
Strategy& Insider Episode 6 - Rewarding health rather than sickness
Opublikowany: 17.02.2020 -
Strategy& Insider Episode 5 - Generating trust within a new model of care
Opublikowany: 30.01.2020 -
Strategy& Insider Episode 4 - Reclaiming the patient-physician relationship
Opublikowany: 2.12.2019 -
Strategy& Insider Episode 3 - How data fuels drug development
Opublikowany: 21.10.2019 -
Strategy& Insider Episode 1 - Fighting cancer with technology
Opublikowany: 8.10.2019 -
Strategy& Insider Episode 2 - Personalized medicine with the help of bioinformatics
Opublikowany: 8.10.2019 -
Strategy& Insider Podcast Trailer
Opublikowany: 30.09.2019
The Strategy& Insider podcast aims to explore some of the most critical future trends and their impacts. Strategy& talks to industry experts and leading practitioners from different sectors. The conversations will make you more familiar with key developments by providing you with insights that really matter. The first season will tackle some of the most fundamental questions in the healthcare industry. While technology has quickly transformed how we shop, bank, and travel, it yet has to impact on how we receive healthcare. The adoption of digitally enabled tools for diagnostics, treatment, and management, for example, has been rather modest - especially compared to what is already possible. Together with experts across all sectors including pharma executives, leading academics and practitioners at hospitals we will discuss how the healthcare industry is expected to change.
